Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

This study has been completed.
Sponsor:
Collaborator:
AstraZeneca
Information provided by:
Mood Disorders Center of Ottawa
ClinicalTrials.gov Identifier:
NCT00252226
First received: November 9, 2005
Last updated: June 2, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)